These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 31822924)
1. The sigma receptor ligand N-phenylpropyl-N'-(4-methoxyphenethyl)3piperazine (YZ-067) enhances the cocaine conditioned-rewarding properties while inhibiting the development of sensitization of cocaine in mice. Tapia MA; Sage AS; Fullerton EI; Judd JM; Hildebrant PC; Will MJ; Lever SZ; Lever JR; Miller DK Psychopharmacology (Berl); 2020 Mar; 237(3):723-734. PubMed ID: 31822924 [TBL] [Abstract][Full Text] [Related]
2. N-Phenylpropyl-N'-(3-methoxyphenethyl)piperazine (YZ-185) Attenuates the Conditioned-Rewarding Properties of Cocaine in Mice. Sage AS; Vannest SC; Fan KH; Will MJ; Lever SZ; Lever JR; Miller DK ISRN Pharmacol; 2013; 2013():546314. PubMed ID: 24089641 [TBL] [Abstract][Full Text] [Related]
3. Effects of N-phenylpropyl-N'-substituted piperazine sigma receptor ligands on cocaine-induced hyperactivity in mice. Sage AS; Oelrichs CE; Davis DC; Fan KH; Nahas RI; Lever SZ; Lever JR; Miller DK Pharmacol Biochem Behav; 2013 Sep; 110():201-7. PubMed ID: 23891829 [TBL] [Abstract][Full Text] [Related]
4. N-phenylpropyl-N'-substituted piperazines occupy sigma receptors and alter methamphetamine-induced hyperactivity in mice. Miller DK; Park ES; Lever SZ; Lever JR Pharmacol Biochem Behav; 2016; 150-151():198-206. PubMed ID: 27851908 [TBL] [Abstract][Full Text] [Related]
5. SA 4503 attenuates cocaine-induced hyperactivity and enhances methamphetamine substitution for a cocaine discriminative stimulus. Rodvelt KR; Lever SZ; Lever JR; Blount LR; Fan KH; Miller DK Pharmacol Biochem Behav; 2011 Feb; 97(4):676-82. PubMed ID: 21115033 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity comparison of YZ-069, a novel sigma ligand, and four analogs in receptor binding and behavioral studies. Matsumoto RR; Potelleret FH; Mack A; Pouw B; Zhang Y; Bowen WD Pharmacol Biochem Behav; 2004 Apr; 77(4):775-81. PubMed ID: 15099923 [TBL] [Abstract][Full Text] [Related]
7. Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade. Romieu P; Phan VL; Martin-Fardon R; Maurice T Neuropsychopharmacology; 2002 Apr; 26(4):444-55. PubMed ID: 11927169 [TBL] [Abstract][Full Text] [Related]
8. Serotonin (2C) receptor regulation of cocaine-induced conditioned place preference and locomotor sensitization. Craige CP; Unterwald EM Behav Brain Res; 2013 Feb; 238():206-10. PubMed ID: 23103406 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships at the monoamine transporters and sigma receptors for a novel series of 9-[3-(cis-3, 5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole) analogues. Husbands SM; Izenwasser S; Kopajtic T; Bowen WD; Vilner BJ; Katz JL; Newman AH J Med Chem; 1999 Oct; 42(21):4446-55. PubMed ID: 10543888 [TBL] [Abstract][Full Text] [Related]
10. The selective sigma(1) receptor agonist, 1-(3,4-dimethoxyphenethyl)-4-(phenylpropyl)piperazine (SA4503), blocks the acquisition of the conditioned place preference response to (-)-nicotine in rats. Horan B; Gardner EL; Dewey SL; Brodie JD; Ashby CR Eur J Pharmacol; 2001 Aug; 426(1-2):R1-2. PubMed ID: 11525784 [TBL] [Abstract][Full Text] [Related]
11. The competitive NMDA receptor antagonist CPP disrupts cocaine-induced conditioned place preference, but spares behavioral sensitization. Carmack SA; Kim JS; Sage JR; Thomas AW; Skillicorn KN; Anagnostaras SG Behav Brain Res; 2013 Feb; 239():155-63. PubMed ID: 23153931 [TBL] [Abstract][Full Text] [Related]
12. Involvement of the sigma1 receptor in the appetitive effects of cocaine. Maurice T; Romieu P Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S198-207. PubMed ID: 15547786 [TBL] [Abstract][Full Text] [Related]
13. Cocaine occupancy of sigma1 receptors and dopamine transporters in mice. Lever JR; Fergason-Cantrell EA; Watkinson LD; Carmack TL; Lord SA; Xu R; Miller DK; Lever SZ Synapse; 2016 Mar; 70(3):98-111. PubMed ID: 26618331 [TBL] [Abstract][Full Text] [Related]
14. Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors. Thanos PK; Bermeo C; Rubinstein M; Suchland KL; Wang GJ; Grandy DK; Volkow ND J Psychopharmacol; 2010 Jun; 24(6):897-904. PubMed ID: 19282420 [TBL] [Abstract][Full Text] [Related]
15. Cocaine conditioned place preference: unexpected suppression of preference due to testing combined with strong conditioning. Marion-Poll L; Besnard A; Longueville S; Valjent E; Engmann O; Caboche J; Hervé D; Girault JA Addict Biol; 2019 May; 24(3):364-375. PubMed ID: 29318708 [TBL] [Abstract][Full Text] [Related]
16. Increased expression of 5-HT6 receptors in the nucleus accumbens blocks the rewarding but not psychomotor activating properties of cocaine. Ferguson SM; Mitchell ES; Neumaier JF Biol Psychiatry; 2008 Jan; 63(2):207-13. PubMed ID: 17631868 [TBL] [Abstract][Full Text] [Related]
17. A novel substituted piperazine, CM156, attenuates the stimulant and toxic effects of cocaine in mice. Xu YT; Kaushal N; Shaikh J; Wilson LL; Mésangeau C; McCurdy CR; Matsumoto RR J Pharmacol Exp Ther; 2010 May; 333(2):491-500. PubMed ID: 20100904 [TBL] [Abstract][Full Text] [Related]
18. Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs. Desai RI; Kopajtic TA; French D; Newman AH; Katz JL J Pharmacol Exp Ther; 2005 Oct; 315(1):397-404. PubMed ID: 16014753 [TBL] [Abstract][Full Text] [Related]
19. Glutathione peroxidase-1 gene rescues cocaine-induced conditioned place preference in mice by inhibiting σ-1 receptor expression. Pham DT; Chung YH; Mai HN; Sharma N; Yun J; Kim HJ; Cheong JH; Jeong JH; Kim DJ; Shin EJ; Kim HC Clin Exp Pharmacol Physiol; 2019 Sep; 46(9):791-797. PubMed ID: 31332816 [TBL] [Abstract][Full Text] [Related]
20. Behavioral effects of rimcazole analogues alone and in combination with cocaine. Katz JL; Libby TA; Kopajtic T; Husbands SM; Newman AH Eur J Pharmacol; 2003 May; 468(2):109-19. PubMed ID: 12742518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]